Helus Pharma Inc. Common Stock
HELP
81 hedge funds and large institutions have $116M invested in Helus Pharma Inc. Common Stock in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 15 closing their positions.
281% more call options, than puts
Call options by funds: $3.06M | Put options by funds: $803K
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
1% more funds holding
Funds holding: 80 → 81 (+1)
13.6% less ownership
Funds ownership: 60.3% → 46.7% (-14%)
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
53% less capital invested
Capital invested by funds: $247M → $116M (-$131M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.97M |
| 2 |
HF
HRT Financial
New York
|
+$1.21M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.04M |
| 4 |
RA
Royce & Associates
New York
|
+$1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$995K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28.5M |
| 2 |
SSC
Spruce Street Capital
New York
|
-$6.3M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$4.9M |
| 4 |
SCM
Squadron Capital Management
Westmont,
Illinois
|
-$4.29M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.5M |
HELP Hedge Fund Activity: Q1 2026 in Review
81 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q1 2026, worth a combined $116M — down 53% from $247M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new HELP positions and 15 closed out — a net gain of 2 holders — while 15 added to existing stakes and 20 trimmed.
The largest buyer was Millennium Management, adding an estimated $8.97M. The largest seller was Point72 Asset Management, cutting an estimated $28.5M.
- 81 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q1 2026, up from 80 in Q4 2025.
- Funds reported $116M of Helus Pharma Inc. Common Stock stock for Q1 2026, down 53% quarter-over-quarter.
- 17 funds opened new Helus Pharma Inc. Common Stock positions in Q1 2026 and 15 closed out, a net change of +2 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q1 2026 was Millennium Management, an estimated $8.97M added.
- The largest Helus Pharma Inc. Common Stock seller in Q1 2026 was Point72 Asset Management, an estimated $28.5M sold.
Based on aggregated 13F filings for Q1 2026.